BRIEF-IDT Australia Undertaking Covid19 Vaccine Feasibility Assessment
- ByReuters-
March 19 (Reuters) - IDT Australia Ltd IDT.AX : * IDT IS UNDERTAKING COVID19 VACCINE FEASIBILITY ASSESSMENT
Symbol | Exchange | Currency |
|---|
March 19 (Reuters) - IDT Australia Ltd IDT.AX : * IDT IS UNDERTAKING COVID19 VACCINE FEASIBILITY ASSESSMENT
June 16 (Reuters) - IDT Australia Ltd IDT.AX : * ANCILA DESAI HAS BEEN APPOINTED AS COMPANY'S CHIEF FINANCIAL OFFICER * ANCILA DESAI REPLACES JOANNA JOHNSON AS CFO
April 9 (Reuters) - IDT Australia Ltd IDT.AX : * IDT AUSTRALIA LTD - TO THIS END IDT'S GMP PHARMACEUTICAL MANUFACTURING FACILITIES AND LABORATORY REMAIN FULLY OPERATIONAL
Dec 24 (Reuters) - IDT Australia Ltd IDT.AX : * CO HAS TERMINATED ITS U.S. DISTRIBUTION AGREEMENT WITH MAYNE PHARMA GROUP
Oct 14 (Reuters) - IDT Australia Ltd IDT.AX : * DEVELOPMENT AGREEMENT FOR DEVELOPMENT OF GMP CANNABIDIOL ACTIVE PHARMACEUTICAL INGREDIENT TO NOT BE EXTENDED PAST NATURAL...
Sept 4 (Reuters) - IDT Australia Ltd IDT.AX : * FDA LIFTS IDT AUSTRALIA LIMITED'S WARNING LETTER
Aug 28 (Reuters) - IDT Australia Ltd IDT.AX : * U.S. FDA CONCLUDED INSPECTION CLASSIFICATION OF IDT'S FACILITY BE RESTORED TO VOLUNTARY ACTION INDICATED
Aug 27 (Reuters) - IDT Australia Ltd IDT.AX : * DEPARTMENT OF HEALTH GRANTS ITS FIRST MEDICINAL CANNABIS MANUFACTURING PERMIT TO CO
May 20 (Reuters) - IDT Australia Ltd IDT.AX : * SECURES MEDICINAL CANNABIS MANUFACTURING LICENCE FROM OFFICE OF DRUG CONTROL
Feb 19 (Reuters) - IDT Australia Ltd IDT.AX : * IDT AUSTRALIA LTD - HY REVENUE $6.5 MILLION VERSUS $5 MILLION * IDT AUSTRALIA LTD - LOSS FOR HALF YEAR $2.4 MILLION VERSUS $17.2...